When was Inso Bio founded?

Inso Bio was founded in 2020 and raised its 1st funding round within a year of its incorporation.

Where is Inso Bio located?

Inso Bio is headquartered in Ithaca, United States.

Who is the current CEO of Inso Bio?

Harvey Tian of Inso Bio. They have also founded 1 company.

How many employees does Inso Bio have?

As of Aug 31, 2026, the latest employee count at Inso Bio is 4.

Is Inso Bio a funded company?

Inso Bio is a funded company, having raised a total of $2.8M across 6 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jan 01, 2020.

When was the latest funding round of Inso Bio?

Inso Bio's latest funding was a $***** Seed round on Mar 03, 2026, with participation from 0 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $1.62B in funding in 2026 to date.

Where does Inso Bio rank among its competitors?

Inso Bio ranks 11th amongst 93 active competitors, of which 13 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Inso Bio, which secured $750K in Mar, 2026.

Who are the top competitors of Inso Bio?

Inso Bio's top competitors include Evosep, AcouSort and Curiox. Among them, Inso Bio secured the most recent funding round in March, 2026.

Inso Bio - 2026 Company Profile, Team, Funding & Competitors

Inso Bio is a seed company based in Ithaca (United States), founded in 2020 by Harvey Tian and Adam Bisogni. It operates as a Developer of a microfluidic-based automated device used for sample preparation. Inso Bio has raised $2.8M in funding from IndieBio and 2048 Ventures. The company has 93 active competitors, including 13 funded and 10 that have exited. Its top competitors include companies like Evosep, AcouSort and Curiox.

Company Details

Developer of a microfluidic-based automated device used for sample preparation. The company uses its patented lab-on-chip microfluidic technology for the processing of the cellular sample. It has applications in long-read DNA sequencing, multi-omic analysis, and pathogen isolation.

Key Metrics

Founded Year

2020

Location

Ithaca, United States

Stage

Seed

Total Funding

$2.8M in 6 rounds

Latest Funding Round

Seed, Mar 03, 2026, $*****

Investors

IndieBio & 9 more

Ranked

11^th among 93 active competitors

Employee Count

4 as on Aug 31, 2026

Similar Companies

Evosep & 109 more

View Inso Bio's full profile

Inso Bio is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Inso Biosciences Inc. CIN: 830928626 , United States, Active	Dec 31, 2019	-	-	-

Inso Bio has raised a total funding of $2.8M over 6 rounds. Its first funding round was on Jan 01, 2020. Inso Bio has 10 institutional investors.

Here is the list of recent funding rounds of Inso Bio:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 03, 2026	9752448	Seed	1352782	2091825	7974991	7050669
Jul 01, 2023	7613943	Grant (prize money)	5755695	9411378	1606513	HHS
Feb 25, 2022	5878169	Seed	3130294	2634839	2048 Ventures	SOSV & 3 more

Access funding benchmarks and valuations. Sign up today!

View details of Inso Bio's funding rounds and investors

The founders of Inso Bio are Harvey Tian and Adam Bisogni. Harvey Tian is the CEO of Inso Bio.

Here are the details of Inso Bio's key team members:

Harvey Tian: Co-Founder & CEO of Inso Bio.
Contact Info: 1 email address
Adam Bisogni: Co-Founder of Inso Bio.
Contact Info: 1 email address

View details of Inso Bio's Founder profiles and Board Members

Inso Bio's employee count trend

Inso Bio has 4 employees as of Aug 26. Here is Inso Bio's employee count trend over the years:

Uncover Inso Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Inso Bio include Evosep, AcouSort and Curiox. Here is the list of Top 10 competitors of Inso Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Evosep 2016, Odense (Denmark), Acquired	Developer of solutions for clinical proteomics	$48.8M	Novo Holdings, Danmarks Eksport og Investeringsfond ... & 1 others	59/100
2nd	AcouSort 2010, Lund (Sweden), Seed	Developer of a microfluidic-based technology called acoustofluidics	$214K	EIC Fund, Nolsterby Invest & 2 others	49/100
3rd	Curiox 2007, Seoul (South Korea), Public	Developer of wall-less plates and washers for automated cell-based assays	$30M	KB Investment, New Asia Investments & 13 others	46/100
4th	Pressure BioSciences 1978, Easton (United States), Public	Platform technology to control biomolecular reactions	-	NIH, HHS	44/100
5th	nRichDX 2016, Irvine (United States), Unfunded	Provider of the devices for liquid biopsy for molecular testing	-	-	42/100
6th	inveox 2017, Munich (Germany), Series A	Manufacturing automated laboratory solutions for biopsy sample preparation	$25.8M	Kacu Systemic, Startup Creasphere & 7 others	41/100
7th	AutoGen 1996, Holliston (United States), Unfunded	Provider of automated DNA and RNA extraction systems	-	-	41/100
8th	Ovizio 2009, Brussels (Belgium), Series A	Developer of an imaging system for microscopes	$9.34M	New Science Ventures, EIC Fund & 6 others	41/100
9th	LabLogic Systems 1980, Sheffield (United Kingdom), Unfunded	Provider of instruments and software for life science and nuclear medicine	-	-	38/100
10th	Annaida 2018, Lausanne (Switzerland), Seed	Developer of sensor using magnetic resonance	$1.06M	Hemex, Venture Kick & 10 others	36/100
11th	Inso Bio 2020, Ithaca (United States), Seed	Developer of a microfluidic-based automated device used for sample preparation	$2.8M	Whitecap Venture Partners, SOSV & 8 others	35/100